Skip to main content
. Author manuscript; available in PMC: 2013 Jul 18.
Published in final edited form as: J Thorac Oncol. 2007 Jul;2(7):638–644. doi: 10.1097/JTO.0b013e318074bbd0

TABLE 1.

Patient Characteristics

Weekly
Docetaxel and
Cisplatin (n = 16)
Every 3 wk
Docetaxel and
Cisplatin (n = 11)
Median age, yr (range) 64 (47–71) 63 (42–71)
Women, no. (%) 8 (50) 6 (55)
Karnofsky performance status, no. (%)
   80% 1 (6) 5 (45)
   90% 15 (94) 6 (55)
Type of surgery, no. (%)
   Lobectomy 15 (94) 9 (82)
   Pneumonectomy 1 (6) 1 (9)
   Wedge resection 0 1 (9)
Stage, no. (%)
   IB 5 (31) 2 (18)
   IIA 3 (19) 2 (18)
   IIB 1 (6) 4 (37)
   IIIA 5 (31) 1 (9)
   IIIB 2 (13) 2 (18)
Histology, no. (%)
   Adenocarcinoma 8 (50) 8 (73)
   Squamous carcinoma 2 (13) 2 (18)
   Adenosquamous 3 (19) 1 (9)
   Large cell 1 (6) 0
   Poorly differentiated 1 (6) 0
   Bronchioloalveolar 1 (6) 0
Days from surgery to 1st chemotherapy (range) 50 (22–55) 50 (40–79)